Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/5/14 → 5/5/17 |
Funding
- Amgen, Inc. (Prot #20110144)
Prot #20110144: A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-2
- Ruderman, Eric M (PD/PI)
Project: Research project